GGrantIndex
← Search

Phase I/II Trial of CCI-779 in Patients with Malignant Gliomas (NABTC 01-01)

$6,821M01FY2004RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →